Viromed Medical

On 09.06.2026 board member Perbandt, Uwe, acquired 500 Viromed Medical shares at €7.12 each; BaFin was informed of the proprietary transaction on 11.06.2026. Previously, on 03.06.2026 Perbandt had already bought 525 shares at €7.45 each. The stock rose intraday and last traded around €6.90–7.00; market capitalization is about €139.73 million. » Más en finanzen.net

Board member Uwe Perbandt acquired a total of 525 Viromed Medical shares at €7.45 each on 3 June 2026; he had previously bought 2,000 shares at €6.60 on 27 May 2026. On the day of the transaction the stock temporarily rose in the FSE session by 3.5% to €7.45, but later closed at €6.90 (-2.80%). Market capitalization is around €144.79 million with a free float of 20,250,000 shares. » Más en finanzen.net

Board member Perbandt, Uwe, bought a total of 2,000 Viromed Medical shares at EUR 6.60 each on 27 May 2026; the transaction was officially reported on 1 June 2026. Previously, Perbandt had already purchased 9,677 shares at EUR 6.68 each on 13 May 2026. After the BaFin notification the stock showed short-term price movements and closed in FSE trading at EUR 6.30; market capitalization is around EUR 127.58 million. » Más en finanzen.net